SCHEMBL383693

SCHEMBL383693

c1ccc2c(c1)ccc1c3ccccc3c(-c3cc4c5ccccc5ccc4c4ccccc34)cc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 0.74
ALDH1A1 P00352 5/20 0.63
HSD17B10 Q99714 3/20 0.63
CYP2A6 P11509 1/20 0.63
TSHR P16473 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
HIF1A Q16665 2/20 0.59
CYP1B1 Q16678 2/20 0.59
PAX8 Q06710 1/20 0.52
CYP1A2 P05177 5/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
HPGD P15428 3/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.48
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48
TP53 P04637 1/20 0.48
CYP2D6 P10635 1/20 0.48
ALOX12 P18054 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30915551 0.95 HPRT1 (0.67) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL30915550 0.91 HPRT1 (0.61) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL4442152 0.86 ALDH1A1 (0.55) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL338303 0.86 HPRT1 (0.61) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL25510 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
Chrysene SCHEMBL9786466 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL31177955 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
Chrysene SCHEMBL384031 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
Chrysene SCHEMBL27115 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR
Chrysene SCHEMBL30433768 0.86 HPRT1 (1.00) HPRT1ALDH1A1HSD17B10CYP2A6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408729-B1 NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND CANON KK (JP) 2015-12-16 EP disclosed
US-8580400-B2 Bichrysene compound and organic light emitting device having the compound CANON KABUSHIKI KAISHA (JP) 2013-11-12 US disclosed
EP-2408729-A1 NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND Canon Kabushiki Kaisha (JP) 2012-01-25 EP disclosed
US-20110272683-A1 NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2011-11-10 US disclosed
WO-2010107097-A1 NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110272683-A1 NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND PPOX, CRY1, OXER1 HPRT1 502/4885ALDH1A1 414/4885HSD17B10 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.